Trilogy EV300, Product numbers CA2200X12B, DS2200X11B, FX2200X15B, IN2200X15B

FDA Device Recall #Z-2289-2021 — Class II — July 26, 2021

Recall Summary

Recall Number Z-2289-2021
Classification Class II — Moderate risk
Date Initiated July 26, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Respironics, Inc.
Location Murrysville, PA
Product Type Devices
Quantity 18936 (US); 4659 (OUS)

Product Description

Trilogy EV300, Product numbers CA2200X12B, DS2200X11B, FX2200X15B, IN2200X15B

Reason for Recall

Two software issues have been identified related to pressure increase in the device: The first issue is described as "Infant/Pediatric EFS Calibration Pressure Increase" and the second issue is described as "Pressure Drift (Continuous Usage).

Distribution Pattern

Worldwide distribution - US nationwide distribution.

Lot / Code Information

Software version numbers 1.02.01.00, 1.03.05.00, 1.03.07.00, 1.04.02.00, 1.04.06, 1.05.01, and 1.06.02

Other Recalls from Philips Respironics, Inc.

Recall # Classification Product Date
Z-1617-2026 Class I Philips Respironics Trilogy Evo Universal, Soft... Mar 2, 2026
Z-1615-2026 Class I Philips Respironics Trilogy Evo O2, Software Ve... Mar 2, 2026
Z-1616-2026 Class I Philips Respironics Trilogy EV300, Software Ver... Mar 2, 2026
Z-1614-2026 Class I Philips Respironics Trilogy Evo, Software Versi... Mar 2, 2026
Z-0481-2026 Class II SimplyGo Mini, Standard Battery Kit; Product c... Oct 7, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.